Acquired EGFR L718V Mutation as the Mechanism for Osimertinib Resistance in a T790M-Negative Non-Small-Cell Lung Cancer Patient Zhe YangJinqi YangXing Wang Therapy in Practice 13 July 2019 Pages: 369 - 374
The Role of Checkpoint Inhibitors in Glioblastoma Kunal DesaiAnne HubbenManmeet Ahluwalia Review Article 09 July 2019 Pages: 375 - 394
Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status: A Systematic Review and Network Meta-Analysis Jisun ParkJinhyun ChoJinchul Kim Systematic Review 09 July 2019 Pages: 395 - 403
Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data Michael MoranDana NickensKate Fife Systematic Review Open access 12 July 2019 Pages: 405 - 416
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up Anna W. ChalmersShiven PatelWallace Akerley Original Research Article 25 July 2019 Pages: 417 - 421
Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma Changhui LiBo ZhangXueyan Zhang Original Research Article 03 July 2019 Pages: 423 - 431
Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib Chih-Hsi Scott KuoChi-Hsien HuangCheng-Ta Yang Original Research Article 25 July 2019 Pages: 433 - 440
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane Annelieke E. C. A. B. WillemsenJolien TolCarla M. L. van Herpen Original Research Article Open access 19 July 2019 Pages: 441 - 451
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma Hiroki IshiharaHidekazu TachibanaKazunari Tanabe Original Research Article 29 July 2019 Pages: 453 - 463
Combination Treatment with an Antibody–Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer Y. Louise WanPuja SapraPeter L. Stern Original Research Article Open access 22 July 2019 Pages: 465 - 477
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma Fares NigimJuri KiyokawaHiroaki Wakimoto Original Research Article 12 July 2019 Pages: 479 - 489
Correction to: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma Changhui LiBo ZhangXueyan Zhang Correction 17 July 2019 Pages: 491 - 491